Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

The judgment in the case of A and Others discussed testing in respect of non-A non-B Hepatitis/Hepatitis C and how raised ALT levels could suggest an abnormality of liver function; but also that it was only a possible indicator of hepatitis, not a test for it.

  • Read more about The judgment in the case of A and Others discussed testing in respect of non-A non-B Hepatitis/Hepatitis C and how raised ALT levels could suggest an abnormality of liver function; but also that it was only a possible indicator of hepatitis, not a test for it.

An article by Professor Cash discussed the original method of testing for the Australia antigen and noted that it lacked sensitivity, unlike the counter-current immunoelectro-osmophoresis technique which was 10-15 times more sensitive with a quicker results time.

  • Read more about An article by Professor Cash discussed the original method of testing for the Australia antigen and noted that it lacked sensitivity, unlike the counter-current immunoelectro-osmophoresis technique which was 10-15 times more sensitive with a quicker results time.

A study discovered the Australia antigen in patients who received a large number of transfusions. Sera from patients with haemophilia were tested for the presence of the isoprecipitins.

  • Read more about A study discovered the Australia antigen in patients who received a large number of transfusions. Sera from patients with haemophilia were tested for the presence of the isoprecipitins.

A journal article described studies which isolated what was previously known as serum hepatitis or the Australia antigen and said that the presence of the Australia antigen in thalassemia and haemophilia patients could be due to the virus being introduced by transfusions.

  • Read more about A journal article described studies which isolated what was previously known as serum hepatitis or the Australia antigen and said that the presence of the Australia antigen in thalassemia and haemophilia patients could be due to the virus being introduced by transfusions.

At a meeting of regional transfusion directors it was reported that the Department of Health had distributed the report of the advisory group on testing for the presence of the Australia (hepatitis-associated) antigen and its antibody and that the Department had accepted the recommendation that all donations should be tested for the presence of the antigen.

  • Read more about At a meeting of regional transfusion directors it was reported that the Department of Health had distributed the report of the advisory group on testing for the presence of the Australia (hepatitis-associated) antigen and its antibody and that the Department had accepted the recommendation that all donations should be tested for the presence of the antigen.

At a meeting of regional transfusion directors they confirmed that all RTCs were testing for the Australian antigen and antibody. Dr Maycock reported that although BPL had been testing all plasma received since November 1971, some dried plasma in central storage had not been tested and he would write to directors about arrangements for testing.

  • Read more about At a meeting of regional transfusion directors they confirmed that all RTCs were testing for the Australian antigen and antibody. Dr Maycock reported that although BPL had been testing all plasma received since November 1971, some dried plasma in central storage had not been tested and he would write to directors about arrangements for testing.

The memo prepared by the medical officers of the Ministry of Health stated that any doubt as to the reality of the association of homologous serum jaundice and hepatitis was removed by the frequency with which hepatitis had followed the injection of human blood products.

  • Read more about The memo prepared by the medical officers of the Ministry of Health stated that any doubt as to the reality of the association of homologous serum jaundice and hepatitis was removed by the frequency with which hepatitis had followed the injection of human blood products.

In a memo prepared by the medical officers of the Ministry of Health it was reported that 1,289 people employed in a shipbuilding yard in Bremen had developed jaundice after being vaccinated with glycerinated humanised lymph.

  • Read more about In a memo prepared by the medical officers of the Ministry of Health it was reported that 1,289 people employed in a shipbuilding yard in Bremen had developed jaundice after being vaccinated with glycerinated humanised lymph.

Sir Colin Walker, in the foreword to Dr Gunson's "Fifty Years of Blood Transfusion", said that the UK's blood supply was amongst the safest in the world but, even so, medical advice was always likely to be that the best transfusion was no transfusion.

  • Read more about Sir Colin Walker, in the foreword to Dr Gunson's "Fifty Years of Blood Transfusion", said that the UK's blood supply was amongst the safest in the world but, even so, medical advice was always likely to be that the best transfusion was no transfusion.

In evidence to the Inquiry, the Medical Ethics Expert Panel confirmed that it is a fundamental ethical principle for a patient to be informed of the risks which are material and significant to them even if that means they might refuse a particular treatment.

  • Read more about In evidence to the Inquiry, the Medical Ethics Expert Panel confirmed that it is a fundamental ethical principle for a patient to be informed of the risks which are material and significant to them even if that means they might refuse a particular treatment.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 468
  • Page 469
  • Page 470
  • Page 471
  • Current page 472
  • Page 473
  • Page 474
  • Page 475
  • Page 476
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.